Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of an Alternative Modified Live Influenza B Virus Vaccine.

Journal of virology - 15 Jun 2017

Santos Jefferson J S, Finch Courtney, Sutton Troy, Obadan Adebimpe, Aguirre Isabel, Wan Zhimin, Lopez Diego, Geiger Ginger, Gonzalez-Reiche Ana Silvia, Ferreri Lucas, Perez Daniel R

Abstract excerpt

Influenza B virus (IBV) is considered a major human pathogen, responsible for seasonal epidemics of acute respiratory illness. Two antigenically distinct IBV hemagglutinin (HA) lineages cocirculate worldwide with little cross-reactivity. Live attenuated influenza virus (LAIV) vaccines have been shown to provide better cross-protective immune responses than inactivated vaccines by eliciting local mucosal immunity...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigenic Variation
Share to Immunity, Humoral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Influenza B virus

Share to Influenza, Human

Share to Influenza Vaccines

Share to Orthomyxoviridae Infections

Share to Vaccines, Attenuated

Share to Vaccines, Inactivated

Source

Open in PubMed Open full text

Identifiers

PMID: 28381580
DOI: 10.1128/JVI.00056-17
PMCID: PMC5446642

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of an Alternative Modified Live Influenza B Virus Vaccine.PMID 28381580Read ↗

A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines.Semantic proximity Read ↗

Mutation E48K in PB1 Polymerase Subunit Improves Stability of a Candidate Live Attenuated Influenza B Virus VaccineSemantic proximity Read ↗

Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.Semantic proximity Read ↗

A Reassortment-Incompetent Live Attenuated Influenza Virus Vaccine for Protection against Pandemic Virus StrainsSemantic proximity Read ↗

FluB-RAM and FluB-RANS: Genome re-arrangement as safe and efficacious live attenuated influenza B virus vaccines.Semantic proximity Read ↗

Influenza B: Prospects for the Development of Cross-Protective VaccinesSemantic proximity Read ↗

Modified Live Attenuated Influenza B Virus Vaccines and Sex-driven Differences on Humoral Immune Responses in the DBA/2J Mouse ModelSemantic proximity Read ↗

Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary useSemantic proximity Read ↗

Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type NucleoproteinSemantic proximity Read ↗

A Mutated PB1 Residue 319 Synergizes with the PB2 N265S Mutation of the Live Attenuated Influenza Vaccine to Convey Temperature Sensitivity.Semantic proximity Read ↗

A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates.Semantic proximity Read ↗

Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza VaccineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.